Skip to content

Clinical trials

Postoperative Pain trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Postoperative Pain Country / region: China Clear all

227 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20073
20083
20091
20103
20112
20122
20133
20147
20154
20166
20177
201813
201913
202014
202114
202227
202327
202422
202523
202630

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108
Unknown status57
Recruiting44
Not yet recruiting11
Withdrawn2
Enrolling by invitation2
Terminated1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Tiantan Hospital22
Huazhong University of Science and Technology10
Peking Union Medical College Hospital8
Peking University First Hospital8
The Second Affiliated Hospital of Chongqing Medical University8
Second Affiliated Hospital, Zhejiang University, School of Medicine7
Tianjin Medical University General Hospital7
General Hospital of Ningxia Medical University6
Nanjing Medical University6
Chinese PLA General Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Postoperative Pain227
Pain18
Agnosia17
Acute Pain8
Chronic Pain7
Emergence Delirium7
Lung Neoplasms5
Postoperative Cognitive Complications5
Breast Neoplasms4
Delirium3

Trials

Showing 1 to 25 of 227. Each trial links to its page on Pharma Observatory.

127 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.